PAG
CABA icon

Private Advisor Group’s Cabaletta Bio CABA Stock Holding History

Private Advisor Group’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,025
Closed -$48.5K – 2566
2026
Q1 		$48.5K Buy
18,025
+3,300
+22% +$9.16K ﹤0.01% 2580
2025
Q4 		$32.2K Buy
+14,725
New +$36.5K ﹤0.01% 2542
2020
Q3 		– Sell
-900
Closed -$10K – 1821
2020
Q2 		$10K Buy
+900
New +$6.89K ﹤0.01% 2917

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Private Advisor Group's CABA Position: Q2 2026 in Review

Private Advisor Group sold out of Cabaletta Bio (CABA) in Q2 2026, closing a stake of 18,025 shares — an estimated $48.5K sold.

Private Advisor Group first reported a position in CABA in Q2 2020 and held it in 3 quarters. The position peaked at $48.5K in Q1 2026. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Private Advisor Group reported no remaining Cabaletta Bio position as of Q2 2026 after selling out during the quarter.
  • Private Advisor Group sold 18,025 Cabaletta Bio shares in Q2 2026, an estimated $48.5K.
  • Private Advisor Group first reported a position in Cabaletta Bio in Q2 2020 and held it in 3 quarters.
  • Private Advisor Group's Cabaletta Bio position peaked at $48.5K in Q1 2026.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.